Author

B. Almassian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

T. O. Yarovinsky· 2 shared V. Nakaar· 2 shared A. B. Alvero· 1 shared A. Chattopadhyay Pal· 1 shared A. Fox· 1 shared B. Madina· 1 shared B. R. Madina· 1 shared C. Chiale· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

T. O. Yarovinsky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivSep 27, 2023

Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory

A. B. Alvero, A. Fox, B. Madina…·G. Mor

This paper develops CARG-2020, a virus-like-vesicle that modulates immune responses to enhance anti-tumor immunity and establish immunological memory in ovarian cancer.

DOI 10.1158/2326-6066.cir-23-0127

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivFeb 19, 2019

Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B

T. O. Yarovinsky, S. W. Mason, M. Menon…·V. Nakaar

This paper develops virus-like vesicles (VLV) expressing multiple HBV antigens for immunotherapy of chronic hepatitis B, showing 40% efficacy in a mouse model.

DOI 10.1016/j.isci.2019.10.040

mouseexperimental assay

𝕏 PostBluesky